Inactive

**Amendment 1 to 22-07-NavyMultiTopic extends the due date from March 21, 2022 to March 28, 2022 Noon Eastern Time. The Medical Technology Enterprise Consortium (MTEC) is excited to post this announce... **Amendment 1 to 22-07-NavyMultiTopic extends the due date from March 21, 2022 to March 28, 2022 Noon Eastern Time. The Medical Technology Enterprise Consortium (MTEC) is excited to post this announcement for a Request for Project Proposals (RPP) focused on the advancement of engineering and medical prototypes and knowledge products related to a broad range of medical technological needs identified in the focus areas listed below. Relevance to the enhanced readiness and resilience of Navy and Marine Corps health and performance is a key feature of this RPP. Background Due to the Navy and Marine Corps’ diverse warfighting capabilities, Sailors and Marines (and Joint Service members) operate in a vast array of challenging and austere environments. Combination of physical and mental stress from extreme conditions compromise human performance capability, increasing risk and possible failure of mission objectives. In addition, operating environments cause complications and challenges in medical logistics and casualty management, both vital elements to ensuring survivability of combat casualties. To maintain warfighter lethality and operational effectiveness in challenging environments, next generation biomedical products are required. Technology Focus Areas Proposed prototypes shall be at a KRL or TRL of 5 at the time of submission or by the anticipated award date (at or around September 30, 2022). Full definitions of TRLs can be found here. More information regarding KRLs can be found here. Please note that this RPP is intended only for submission of new projects or substantially revised or modified proposals in accordance with previous Government feedback, and not identical resubmissions from previous MTEC NavyMultiTopic solicitations (including the 20-02-NavyMultiTopic and 21-10-NavyMultiTopic). Proposed prototype solutions shall address ONE of the Technology Focus Areas and ONE of the associated Specific Areas of Interest outlined below in support of the Naval Advanced Medical Development (NAMD). Offerors are not limited to a single white paper submission. White Papers not aligned to ONE of these Focus Areas (and ONE of the associated Specific Areas of Interest) may not be considered for award. These Technology Focus Areas are not listed in order of importance. FOCUS AREA #1: Combat Casualty Wound and Infection Care: This area focuses on patient care at and through the continuum of care as well as products and services that sustain patient (warfighter) health in austere environments such as expeditionary, littoral, and deep water. Specific areas of interest are as follows (Offerors shall address only one of these in each White Paper submission): Wound care treatments / therapies for combat injuries. Includes technologies suitable for use at point of injury and / or at medical facilities in theater Wound care technologies for combat wound infections (e.g., bacterial and other infections of combat wounds) Innovative wound care technologies to treat and prevent biofilm formation Focus Area #2: Military DentaL Research: This area focuses on prevention and treatment of dental and maxillofacial injuries, pain, and infections to improve care for and outcomes of wounded warfighters. Research topics may encompass routine clinical dental care to maintain the resilience and readiness of the warfighter as well as methods or products to treat injuries to the oral cavity, face, and facial bones sustained during combat (e.g., combat density, fracture, burns, etc.). Also of interest are development activities focused on manufacturing readiness of technical solutions. Specific areas of interest are as follows (Offerors shall address only one of these in each White Paper submission): Clinical solutions for dental diseases and emergencies, which may include diagnostic aids, prevention or treatment modalities, restorative biomaterials, medications, therapeutic techniques, clinical guidelines, and/or knowledge products relevant to clinical practice Methods or products to treat maxillofacial injury and trauma sustained during combat for restoring the cosmetic and functional aspects of the face, including fabrication, manufacturing, and performance testing of products such as a solid dressing that contains antimicrobial silver and cerium ions and maintains antimicrobial activity for up to 3 days Military Dental Research Solutions to provide emergency dental care in austere or forward combat environments Focus aRea #3: Human performance: This area focuses on the prediction and monitoring of health status using advanced biomedical and electronics solutions and well as treatments to improve human performance or mitigate negative environmental effects of Navy personnel in militarily-relevant environments (e.g., underwater, surface, and / aviation). Specific areas of interest as follows (Offerors shall address only one of these in each White Paper submission): Development of physiological monitoring systems to include wearable devices and/or tablets for verification and validation of individualized predication algorithms for physical and cognitive performance due to stress in underwater Navy-relevant operational environments Biomedical solutions for the rapid delivery of products to improve the performance of military personnel / or mitigate negative effort of environmental condition conditions during or directly following the symptomatic onset of conditions that may otherwise comprise the efficiency of service members and their performance in militarily relevant environments (e.g., surface [motion-sickness], undersea). Potential for Follow-on Work There is potential for award of one or more follow-on tasks based on the success of any resultant Research Project Awards (subject to change depending upon Government review of work completed and availability of funding). Note that any potential follow-on work is expected to be awarded non-competitively to resultant project awardees and is contingent upon availability of future funding and the successful completion/progression of milestones. Follow-on work may include tasks related to advancement of prototype maturity, and/or to expand the use or utility of the prototype. Acquisition Approach The two-stage approach for this RPP is intended to streamline the initial proposal preparation time and effort for MTEC members. Based on the Government’s evaluation of White Papers in Stage 1, select Offerors will be invited to participate in Stage 2 in one of two distinct approaches. Stage 1: White Papers submitted under this RPP shall follow the MTEC White Paper Template provided in Section 8 of this RPP. Stage 2: The Stage 2 process may vary and may require different submissions compared with typical MTEC RPPs. The Government is utilizing two distinct Stage 2 approaches under this RPP. Stage 2 Approach A: This Stage 2 approach will require a solution pitch (i.e., oral presentation) followed by a written detailed research strategy and full cost proposal (after evaluation of the pitch). Information on cost proposals can be found in Section 7 of the Proposal Preparation Guide. Stage 2 Approach B: This Stage 2 approach will require a full proposal (to include technical and cost volumes) using the MTEC Proposal Preparation Guide. Note that Stage 2 Offerors will only be required to follow one of the aforementioned Stage 2 approaches. Those Offerors that are favorably evaluated during Stage 1 will receive notification letters which will serve as the formal request for a Stage 2 proposal. These letters will contain specific Stage 2 proposal submission requirements and templates. Potential Funding Availability The U.S. Government (USG) currently has available a total of approximately $15 million (M) for anticipated awards to be made during FY2022. The estimated total available funding per Focus Area is as follows (subject to realignment dependent on quality of submissions): Focus Area #1: Combat Casualty Wound and Infection Care ~$8M Focus Area #2: Military Dental Research ~$3-5M Focus Area #3: Human Performance ~$3-4M MTEC anticipates that multiple awards may be made under each Focus Area with average budgets ranging from an anticipated range of $1,750,000 to $8,000,000 (based on individual technical efforts) for the base period of performance (exclusive of any proposed options). Award funding will be structured incrementally and based upon completion of Milestones and Deliverables. The base Periods of Performance (PoP) may range from 12 to 36 months, dependent upon product type and level of maturation required. Dependent on the results and deliverables under any resultant award(s), the USG may apply additional dollars and/or allow for additional time for follow-on efforts with appropriate modification of the award. Cost sharing, including cash and in kind (e.g., personnel or product) contributions are strongly encouraged, have no limit, and are in addition to the Government funding to be provided under the resultant award(s). MTEC The MTEC mission is to assist the U.S. Army Medical Research and Development Command (USAMRDC) by providing cutting-edge technologies and supporting life cycle management to transition medical solutions to industry that protect, treat, and optimize Warfighters’ health and performance across the full spectrum of military operations. MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the U.S. Army Medical Research Acquisition Activity (USAMRAA). MTEC is currently recruiting a broad and diverse membership that includes representatives from large businesses, small businesses, “nontraditional” defense contractors, academic research institutions and not-for-profit organizations. Administrative Information White Papers are due no later than March 21, 2022 at 12:00pm Eastern Time. The RPP is posted to the MTEC website (mtec-sc.org) and a notice is posted on www.SAM.gov to notify interested parties. MTEC membership is required for the submission of a White Paper in response to this MTEC RPP. An Offeror submitting a White Paper as the prime contractor must be an MTEC member of good standing by March 17, 2021. To join MTEC, please visit http://mtec-sc.org/how-to-join/ A Proposers Conference via webinar will be held for interested parties to have their questions answered by the DoD after the RPP is posted. MTEC Members will be notified when the Proposers Conference is scheduled. Points of Contact Please direct your inquiries and correspondence to the following contacts: Questions concerning contractual, cost or pricing related to this RPP should be directed to the MTEC Contracts Administrator at mtec-contracts@ati.org Technical and membership questions – Dr. Gage Greening, MTEC Biomedical Research Associate, gage.greening@mtec-sc.org Administrative questions – Ms. Kathy Zolman, MTEC Director of Program Operations, kathy.zolman@ati.org

Inactive

This is a pre-announcement only. No response is required at this time. The Medical Technology Enterprise Consortium (MTEC) is excited to post this Pre-Announcement for a Request for Project Proposals ... This is a pre-announcement only. No response is required at this time. The Medical Technology Enterprise Consortium (MTEC) is excited to post this Pre-Announcement for a Request for Project Proposals (RPP) focused on the advancement of engineering and medical prototypes and knowledge products related to a broad range of medical technological needs identified in the focus areas listed below. Relevance to the enhanced readiness and resilience of Navy and Marine Corps health and performance is a key feature of this RPP. Background: Due to the Navy and Marine Corps’ diverse warfighting capabilities, Sailors and Marines (and Joint Service members) operate in a vast array of challenging and austere environments. Combination of physical and mental stress from extreme conditions compromise human performance capability, increasing risk and possible failure of mission objectives. In addition, operating environments cause complications and challenges in medical logistics and casualty management, both vital elements to ensuring survivability of combat casualties. To maintain warfighter lethality and operational effectiveness in challenging environments, next generation biomedical products are required. Solution Requirements: Proposed prototype solutions (minimum TRL 5)shall address ONE of the Technology Focus Areas and ONE of the associated Specific Areas of Interest outlined below in support of the NAMD. Offerors are not limited to a single white paper submission. White Papers not aligned toONE of these Focus Areas (and ONE of the associated Specific Areas of Interest) may not be considered for award. These Technology Focus Areas arenot listed in order of importance. FOCUS AREA #1: Combat Casualty Wound and Infection Care: This area focuses on patient care at and through the continuum of care as well as products and services that sustain patient (warfighter) health in austere environments such as expeditionary, littoral, and deep water.Specific areas of interest are as follows (Offerors shall address only one of these in each White Paper submission): Wound care treatments / therapies for combat injuries. Includes technologies suitable for use at point of injury and / or at medical facilities in theater Wound care technologies for combat wound infections (e.g., bacterial and other infections of combat wounds) Innovative wound care technologies to treat and prevent biofilm formation Focus Area #2: Military DentaL Research: This area focuses on prevention and treatment of dental and maxillofacial injuries, pain, and infections to improve care for and outcomes of wounded warfighters. Research topics may encompass routine clinical dental care to maintain the resilience and readiness of the warfighter as well as methods or products to treat injuries to the oral cavity, face, and facial bones sustained during combat (e.g., combat density, fracture, burns, etc.). Also of interest are development activities focused on manufacturing readiness of technical solutions. Specific areas of interest are as follows(Offerors shall address only one of these in each White Paper submission): Clinical solutions for dental diseases and emergencies, which may include diagnostic aids, prevention or treatment modalities, restorative biomaterials, medications, therapeutic techniques, clinical guidelines, and/or knowledge products relevant to clinical practice Methods or products to treat maxillofacial injury and trauma sustained during combat for restoring the cosmetic and functional aspects of the face, including fabrication, manufacturing, and performance testing of products such as a solid dressing that contains antimicrobial silver and cerium ions and maintains antimicrobial activity for up to 3 days Military Dental Research Solutions to provide emergency dental care in austere or forward combat environments Focus aRea #3: Human performance: This area focuseson the prediction and monitoring of health status using advanced biomedical and electronics solutions and well as treatments to improve human performance or mitigate negative environmental effects of Navy personnel in militarily relevant environments (e.g., underwater, surface, and / aviation). Specific areas of interest as follows (Offerors shall address only one of these in each White Paper submission): Development of physiological monitoring systems to include wearable devices and/or tablets for verification and validation of individualized predication algorithms for physical and cognitive performance due to stress in underwater Navy-relevant operational environments Biomedical solutions for the rapid delivery of products to improve the performance of military personnel / or mitigate negative effort of environmental condition conditions during or directly following the symptomatic onset of conditions that may otherwise comprise the efficiency of service members and their performance in militarily relevant environments (e.g., surface [motion-sickness], undersea) Potential Funding Availability and Period of Performance: The U.S. Government (USG) currently has available a total of approximately$15 million (M) for anticipated awards to be made during FY2022. Award and funding from the Government is expected to be limited to the funding specified above and is contingent upon the availability of federal funds for this program. Awards resulting from this RPP are expected to be made under the authority of 10 U.S.C. § 2371b.The estimated total available funding per Focus Area is as follows (subject to realignment dependent on quality of submissions): Focus Area #1: Combat Casualty Wound and Infection Care ~$8M Focus Area #2: Military Dental Research ~$3-5M Focus Area #3: Human Performance ~$3-4M MTEC anticipates thatmultiple awards may be made under each Focus Area with average budgets ranging from an anticipated range of $1,750,000 to $8,000,000 (based on individual technical efforts) for the base period of performance (exclusive of any proposed options). Award funding will be structured incrementally and based upon completion of Milestones and Deliverables. The base Periods of Performance (PoP) may range from12 to 36 months, dependent upon product type and level of maturation required. Acquisition Approach: MTEC recognizes that considerable effort is required to prepare a competitive proposal to MTEC. The two-stage approach for this RPP is intended to streamline the initial proposal preparation time and effort for MTEC members. Based on the Government’s evaluation of White Papers in Stage 1, select Offerors will be invited to participate in Stage 2 and will be required to submit a full proposal for more detailed evaluation. Stage 1: White Papers submitted under this RPP shall follow the MTEC White Paper Template provided in Section 8 of this RPP. Stage 2:The Stage 2 process may vary and may require different submissions compared with typical MTEC RPPs. The Government is utilizing two distinct Stage 2 approaches under this RPP. Stage 2 Approach A: This Stage 2 approach will require a solution pitch (i.e., oral presentation) followed by a written detailed research strategy and full cost proposal (after evaluation of the pitch). Information on cost proposals can be found in Section 7 of the PPG. Stage 2 Approach B: This Stage 2 approach will require a full proposal (to include technical and cost volumes) using the MTEC Proposal Preparation Guide (PPG). Note that Stage 2 Offerors will only be required to follow one of the aforementioned Stage 2 approaches. Those Offerors that are favorably evaluated during Stage 1 will receive notification letters which will serve as the formal request for a Stage 2 proposal. These letters will contain specific Stage 2 proposal submission requirements and templates. This upcoming RPP will be posted to the MTEC website(Caution-https://www.mtec-sc.org/solicitations/ and www.SAM.gov to notify interested parties. The RPP is expected to be released as soon as possible and will have a short proposal preparation period (approximately 30 days). MTEC membership is required for the submission of a White Paper in response to this upcoming MTEC RPP. To join MTEC, please visit Caution-http://mtec-sc.org/how-to-join/. MTEC The MTEC mission is to assist the U.S. Army Medical Research and Development Command (USAMRDC) by providing cutting-edge technologies and supporting life cycle management to transition medical solutions to industry that protect, treat, and optimize Warfighters’ health and performance across the full spectrum of military operations. MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the U.S. Army Medical Research Acquisition Activity (USAMRAA). MTEC is currently recruiting a broad and diverse membership that includes representatives from large businesses, small businesses, “nontraditional” defense contractors, academic research institutions and not-for-profit organizations. Point of Contact For inquiries regarding this pre-announcement, please direct your correspondence to Dr. Gage Greening, MTEC Biomedical Research Associate,gage.greening@mtec-sc.org.